56 unknown. 56 Phase 2, 11 Phase 1, 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 56 | Unknown 56 |
| Phase 1 | 11 | Unknown 11 |
| Phase 3 | 9 | Unknown 9 |
Follow Mood Disorders: new trials by email Literature Review of Mood Disorders trials Research Report on Mood Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of HS-10353 in Adult Participants With Major Depressive Disorder HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules - Major Depressive Disorder (MDD) | Phase 2 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 144 | 2023-08-31 | 2023-07-11 |
| A Phase II Study of HS-10353 in Participants With Postpartum Depression HS-10353 Capsules 30 mg, Oral, QN for 14 days, HS-10353 Capsules 50 mg, Oral, QN for 14 days, HS-10353 Capsules matching placebo, 30mg, Oral, QN for 14 days. - Postpartum Depression | Phase 2 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 96 | 2023-08-31 | 2023-07-10 |
| Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms Non-Invasive Transcranial Focused Ultrasound - Depressive Disorder, Major, Depression | Phase 1 / Phase 2 | Unknown | University of Arizona | 20 | 2023-04-27 | 2024-03-20 |
| The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression Ammoxetine, Placebo - Major Depressive Disorder (MDD) | Phase 2 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 240 | 2023-02-28 | 2023-03-09 |
| PEA vs. Placebo for Major Depression Palmitoylethanolamide - Bipolar Depression, Major Depressive Disorder | Phase 2 | Unknown | The Israeli Medical Center for Alzheimer's | 100 | 2022-12-21 | 2023-10-02 |
| A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care Promoting First Relationships-Brief, Perinatal Collaborative Care - Depression, Postpartum, Efficacy, Self | Phase 2 | Unknown | University of Washington | 60 | 2022-11-01 | 2023-12-22 |
| Microbiotherapy in Characterized Depressive Disorder microbiotherapy (GynMDD), placebo - Depression, Depressive Disorder | Phase 2 | Unknown | Centre Hospitalier Universitaire de Besancon | 92 | 2022-06-08 | 2022-09-09 |
| Brain Insulin Resistance in Mood Disorders Humulin R, Diluent - Major Depressive Disorder, Bipolar Disorder | Phase 1 / Phase 2 | Unknown | University Health Network, Toronto | 150 | 2021-10-06 | 2023-12-15 |
| TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic Transcranial Direct Current Stimulation, Placebo-simulation of transcranial direct current stimulation, Fluoxetine Tablets - Major Depressive Disorder | Phase 2 / Phase 3 | Unknown | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | 172 | 2021-10-01 | 2021-06-04 |
| Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression Ammoxetine hydrochloride enteric-coated tablets, Duloxetine hydrochloride enteric-coated capsules, Placebo to Ammoxetine - Major Depressive Disorder (MDD) | Phase 2 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 240 | 2021-08-21 | 2021-11-12 |
| Psilocybin Versus Ketamine in Treatment-Resistant Depression Psilocybin, Ketamine Hydrochloride, Midazolam Ph. Eur 9.0 - Treatment Resistant Depression | Phase 2 | Unknown | National Institute of Mental Health, Czech Republic | 60 | 2021-05-01 | 2022-05-20 |
| An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients AXS-05, Bupropion SR - Major Depressive Disorder, Treatment Resistant Depression | Phase 2 | Unknown | Axsome Therapeutics, Inc. | 312 | 2021-04-14 | 2021-07-26 |
| The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression MET-2, Placebo - Major Depressive Disorder, Anxiety | Phase 2 | Unknown | NuBiyota | 60 | 2021-04-01 | 2021-05-11 |
| The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder FMT oral Capsules, Placebo Capsules - Depression, Treatment Resistant Depression | Phase 2 / Phase 3 | Unknown | University of Calgary | 80 | 2021-03-04 | 2023-11-28 |
| An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) Psilocybin - Treatment Resistant Depression | Phase 2 | Unknown | Sheppard Pratt Health System | 27 | 2021-03-01 | 2024-08-09 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis | Phase 1 / Phase 2 | Unknown | All Natural Medicine Clinic, LLC | 2000 | 2021-03-01 | 2021-05-26 |
| The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. Psilocybin - Treatment Resistant Depression | Phase 2 | Unknown | Sheppard Pratt Health System | 15 | 2021-03-01 | 2022-10-25 |
| Bear Bile Pill as add-on the Treatment of MDD bear bile pill, placebo - Major Depressive Disorder | Phase 2 | Unknown | Shanghai Mental Health Center | 120 | 2020-10-30 | 2020-08-12 |
| The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder Psilocybin - Major Depressive Disorder | Phase 2 | Unknown | Maryland Oncology Hematology, PA | 30 | 2020-09-01 | 2021-10-15 |
| A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression sulforaphane, placedo, selective 5 - HT reuptake inhibitors (SSRI) - Depressive Disorder | Phase 2 | Unknown | Central South University | 90 | 2020-07-15 | 2020-08-20 |
Showing 20 of 56. Sign in to see all of them.
Depressive Disorder, Major (31) · Depression (12) · Bipolar Disorder (10) · Depressive Disorder, Treatment-Resistant (9) · Depressive Disorder (7) · Anxiety Disorders (6) · Depression, Postpartum (3) · COVID-19 (2) · Neoplasms (2) · Sleep Initiation and Maintenance Disorders (2) · Stress Disorders, Post-Traumatic (2) · Acquired Immunodeficiency Syndrome (1) · Ageusia (1) · Alcoholism (1)
Mental Disorders (56) · Depressive Disorder (38) · Behavior (12) · Behavioral Symptoms (12) · Bipolar and Related Disorders (10) · Pathological Conditions, Signs and Symptoms (5) · Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (4) · Signs and Symptoms (4) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Pathologic Processes (3) · Pregnancy Complications (3) · Puerperal Disorders (3)
Ketamine (4) · Psilocybin (4) · Cognitive Behavioral Therapy (2) · Docosahexaenoic Acids (2) · Memantine (2) · Transcranial Direct Current Stimulation (2) · Vortioxetine (2) · ammoxetine (2) · Acamprosate (1) · Adenosine Triphosphate (1) · Antidepressive Agents (1) · BID protein, human (1) · Cognitive Training (1) · Corn Oil (1) · Duloxetine Hydrochloride (1)
Jiangsu Hansoh Pharmaceutical Co., Ltd. (3) · University of Sao Paulo (3) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (2) · Santa Casa Medical School (2) · Shanghai Mental Health Center (2) · Sheppard Pratt Health System (2) · The University of New South Wales (2) · All Natural Medicine Clinic, LLC (1) · Assistance Publique - Hôpitaux de Paris (1) · Axsome Therapeutics, Inc. (1) · CCTU-Core (1) · Central South University (1) · Centre Hospitalier Universitaire de Besancon (1) · Centre hospitalier de Ville-Evrard, France (1) · Chase Therapeutics Corporation (1)
United States (12) · China (10) · Canada (6) · Brazil (4) · France (3) · Australia (2) · Mexico (2) · South Korea (2) · United Kingdom (2) · Czechia (1) · Iraq (1) · Israel (1) · Moldova (1) · Netherlands (1) · Norway (1)
Gordon B Parker, Dsc MD PhD (2) · Scott Aaronson, MD (2) · Valerie Taylor, MD, PhD (2) · Amritha S Bhat, MD, MPH (1) · Anne EM Speckens, PhD, MD (1) · Anne Marie Rees, BSc MBBS (1) · Beny Lafer, Professor (1) · Daniel T Johnston, MD, MPH (1) · David N Lopez-Garza, M.D. (1) · Dominic TS Lee, M.D. (1) · Dr. Ryan O Lakin, MD JD (1) · Edward Bullmore (1) · Ehud Klein, MD (1) · Huafang Li, Professor (1)
PMID 25150403, PMID 10990547, PMID 11063978, PMID 11723286, PMID 12244081, PMID 12949224, PMID 14677403, PMID 15147306, PMID 15351385, PMID 15987799, PMID 16002441, PMID 16794566, PMID 17591596, PMID 19332318, PMID 19403329, PMID 19671217, PMID 19853048, PMID 20633386, PMID 20884642, PMID 21068312, PMID 21167786, PMID 21631313, PMID 21890211, PMID 22032743, PMID 22189047, PMID 22193671, PMID 22215866, PMID 22341482, PMID 23273725, PMID 23773978, PMID 23851401, PMID 23893039, PMID 23920122, PMID 24029539, PMID 24486425, PMID 25054988, PMID 25153776, PMID 25309825, PMID 25522391, PMID 26321911, PMID 26358492, PMID 27173384, PMID 27535462, PMID 27866120, PMID 28181668, PMID 28330592, PMID 28351410, PMID 28870754, PMID 29066167, PMID 29111077
2018 (1), R34MH124798 (1)